Oxford Gene Technology Ltd - Medical Equipment - Deals and Alliances Profile
December 2018
26
About the Report
About the Report
Summary
Oxford Gene Technology Ltd (OGT) is a provider of genetics research solutions. The company's products comprise fish probes, custom cancer panels, custom AML panel, custom breast cancer panel, custom FH panel, core MPN panel, ovarian cancer panel, myeloid panel and others. It provides medical research exome array, austim research array and epilepsy research array. OGT offers services such as targeted sequencing services, sureseq solid tumour panel sequencing service, RNA-seq service, miRNA analysis, gene expression analysis, cytosure services and aCGH for CNV analysis. The company's are used in cancer research, clinical genetics research, cytogenetics research, molecular genetics research, and pre-implantation genetic screening. OGT is headquartered in Begbroke, the UK.
Oxford Gene Technology Ltd-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Oxford Gene Technology Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Oxford Gene Technology Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Oxford Gene Technology Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Oxford Gene Technology Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Oxford Gene Technology Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Oxford Gene Technology Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Oxford Gene Technology Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Institute of Cancer Research Enters Into Licensing Agreement With Oxford Gene Technology For Prostate Cancer 10
Oxford Gene Technology Enters Into Licensing Agreement With Oslo University Hospital And University of Oslo 11
Oxford Gene Enters Co-Development Agreement With Emory Genetics For New CGH Arrays 12
Oxford Gene Enters into Licensing Agreement with Wellcome Trust Sanger Institute 13
Oxford Gene Technology Enters Into Licensing Agreement With Cancer Cytogenomics Microarray Consortium 14
Asset Transactions 15
Sengenics Acquires Protein Array Technology Platform from Oxford Gene Technology 15
Acquisition 16
Sysmex Acquires Oxford Gene Technology 16
Oxford Gene Technology Acquires Cytocell, Genomic Medicine Company 17
Oxford Gene Technology Ltd-Key Competitors 18
Oxford Gene Technology Ltd-Key Employees 19
Oxford Gene Technology Ltd-Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Strategy And Business Planning 21
Nov 08, 2018: OGT further expands global direct sales and support into Asia-Pacific 21
Corporate Communications 22
Apr 09, 2018: OGT announces organisational changes 22
Product News 23
Apr 25, 2017: OGT's expanded NGS cancer panels enable sequencing of difficult genes 23
Other Significant Developments 24
Jul 02, 2018: OGT expands direct sales and support infrastructure in Europe 24
Jun 12, 2018: OGT expands custom NGS cancer panel content 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26
List of Figure
List of Figures
Oxford Gene Technology Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Oxford Gene Technology Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Oxford Gene Technology Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Oxford Gene Technology Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Oxford Gene Technology Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Oxford Gene Technology Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Oxford Gene Technology Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Oxford Gene Technology Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8
List of Table
List of Tables
Oxford Gene Technology Ltd, Medical Equipment, Key Facts 2
Oxford Gene Technology Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Oxford Gene Technology Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Oxford Gene Technology Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Oxford Gene Technology Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Oxford Gene Technology Ltd, Deals By Market, 2012 to YTD 2018 8
Oxford Gene Technology Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Institute of Cancer Research Enters Into Licensing Agreement With Oxford Gene Technology For Prostate Cancer 10
Oxford Gene Technology Enters Into Licensing Agreement With Oslo University Hospital And University of Oslo 11
Oxford Gene Enters Co-Development Agreement With Emory Genetics For New CGH Arrays 12
Oxford Gene Enters into Licensing Agreement with Wellcome Trust Sanger Institute 13
Oxford Gene Technology Enters Into Licensing Agreement With Cancer Cytogenomics Microarray Consortium 14
Sengenics Acquires Protein Array Technology Platform from Oxford Gene Technology 15
Sysmex Acquires Oxford Gene Technology 16
Oxford Gene Technology Acquires Cytocell, Genomic Medicine Company 17
Oxford Gene Technology Ltd, Key Competitors 18
Oxford Gene Technology Ltd, Key Employees 19
Oxford Gene Technology Ltd, Subsidiaries 20
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.